"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Original article
peer-reviewed

Burdens of Postoperative Infection in Endoscopic Retrograde Cholangiopancreatography Inpatients



Abstract

Objectives

Our objective in this study is, firstly, to determine postoperative (POI) rates in endoscopic retrograde cholangiopancreatography (ERCP) procedures stratified by patients’ demographic and hospitals’ characteristics in the United States, and secondly, to evaluate the demographic and comorbid risk factors associated with POI in ERCP inpatients, as well as its impact on the length of stay (LOS) and total charges.

Methods

The total sample of 28,525 inpatients with a principal procedure of ERCP from the Nationwide Inpatient Sample (NIS) was included and grouped by co-diagnosis of POI (N=300, 1.05%). We used a logistic regression model and descriptive statistics for the POI rate estimates.

Results

High POI rate was seen in males (1.14%), and adults (36-50 years, 1.25%) with 2.65 times (95% CI 1.69-4.12) higher odds compared to young adults. POI rate in ERCP inpatients varied widely according to geographic region: higher in the West (1.46%) and Northeast (1.20%) and lowest in the Midwest (0.70%). As per the hospital characteristics, inpatients in public (1.26%), urban teaching (1.39%) and small bed-size (1.27%) hospitals had higher POI rates. ERCP inpatients with POI had higher odds of association with comorbid HIV infection (OR 1.55, 95% CI 1.13-2.12) and diabetes (OR 1.43, 95% CI 1.09-1.85). ERCP inpatients with POI had a significantly longer length of stay (LOS) by 5.2 days and higher total charges by USD 53,966 than inpatients without POI.

Conclusions

POI is associated with acute inpatient care, with longer hospitalization stays and higher costs, leading to increased healthcare burdens. The main goal is to identify the risk factors and to prevent POI with prophylactic antibiotics.

Introduction

Since its introduction in 1968, endoscopic retrograde cholangiopancreatography (ERCP) has become a commonly performed endoscopic procedure. The diagnostic and therapeutic utility of ERCP has been well demonstrated for a variety of disorders, including the management of choledocholithiasis, biliary and pancreatic neoplasms, and the postoperative management of biliary perioperative complications [1]. ERCP is the primary therapeutic procedure for the treatment of diseases that affect the biliary tree and pancreatic duct [2]. While the therapeutic success rate of ERCP is high, the procedure can cause complications, such as acute pancreatitis, bleeding, and perforation [3]. The significance of post-ERCP complications reveals the necessity of their avoidance by adopting additional measures if risk factors are identified [4].

Post-ERCP infections are reported to occur in less than five percent of all interventions [5]. High hygienic standards for the intervention itself and thorough disinfection and storage of endoscope and endoscopic devices have fundamentally attributed to this low infectious rate [6]. Procedural improvements such as endoscopic decompression by biliary stents and immediate placement of percutaneous biliary drainage if endoscopic drainage is not possible, represent further strategies to reduce the incidence of ERCP-related infectious complications [7].

Complications related to ERCP is an important issue as the failure to restore adequate drainage after injection of contrast media into obstructed bile tracts during ERCP still represents the major risk factor for post-ERCP infection [8]. Our first objective in this study is to provide a descriptive overview of the postoperative infection (POI) following ECRP procedure during hospitalization and determine the rates of POI stratified by patients’ demographic characteristics and hospitals’ characteristics in the United States, and associated comorbid risk factors. The second objective is to evaluate the demographic and comorbid risk factors associated with POI in ERCP inpatients, and its impact on the length of stay (LOS) and total charges.

Materials & Methods

We conducted a retrospective cross-sectional study using the data from 2012 to 2014 Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) [9]. The NIS is the largest publicly available nationwide inpatient database from a sampling of 4,411 hospitals across 45 states representing a pool of about 20% of the US hospitals [9].

Patient variables included in this study are age, gender, race, median household income, primary payer, diagnosis, principal procedure, LOS, and total charges [10]. Hospital variables drawn from the American Hospital Association (AHA) Annual Survey of Hospitals included ownership, bed size, location/teaching status, and region [10]. The region was summarized based upon U.S. Census Bureau and AHA Annual Survey of Hospitals [10].

We included adult inpatients (18 to 65 years) who had a principal procedure of ERCP (ICD-9 procedure code, 51.10). These inpatients were divided into groups, with and without POI (ICD-9 diagnosis code, 998.59). We used cross-tabulations to obtain a descriptive overview of the rate of POI in ERCP inpatients stratified by their sociodemographic characteristics as well as hospital characteristics. Differences in continuous variables like LOS and total charges between POI and non-POI groups were measured using the independent sample t-test. Risk factors that may predispose POI in ERCP inpatients were identified by ICD-9 diagnosis or clinical classification software (CCS) codes namely, bile duct perforation (ICD-9 576.3), obstruction of the stent (ICD-9 576.2), diabetes (CCS code 49) and human immunodeficiency virus (HIV) infection (CCS code 5). Logistic regression model adjusted for age, gender, and the race were conducted to estimate the odds ratio (OR) of these risk factors for POI in ERCP inpatients.

We used SPSS version 25 (IBM Corporation, Armonk, New York) to analyze the NIS data and apply discharge weights [10] to attain a nationally representative sample. We used a logistic regression model and descriptive statistics with 95% confidence intervals (CI) for the POI rate estimates, and the statistical significance was set at P-value < 0.05.

Results

From 2012 to 2014, a total of 28,525 ERCP as a primary procedure were conducted with only 300 inpatients with co-diagnoses of POI (1.05%). Relatively high rates of POI were seen in adults (36-50 years, 1.25%) with 2.65 times (95% CI 1.69 - 4.12) higher odds of association compared to young adults (18-35 years). As per other race/ethnicity and gender, we did not find statistically significant differences in POI with the highest rate seen in male (1.14%) and white (1.27%). In the adjusted regression model, Native Americans have 4.7-fold higher odds (95% CI 2.44 - 0.19) for POI compared to white. A higher rate of POI was observed in Medicare (1.22%) and private insurance (1.08%) beneficiaries.

POI rate in ERCP inpatients was diverse broadly by geographic region in the US. The rate of POI was higher in the West (1.46%) and the Northeast (1.20%) followed by the South (0.94%) and lowest in the Midwest (0.70%). As per the hospital characteristics, patients in public (1.26%), urban teaching (1.39%) and small bed-size (1.27%) hospitals had higher rates of POI compared to their respective counterparts. The rate of POI in ERCP inpatients varied extensively across sociodemographic and hospital strata as shown in Table 1.

Characteristic Total (N= 28525) POI (N= 300) POI rate P-value
Age at admission (in years)
  18 – 35 5670 25 0.44% <0.001
  36 – 50 8375 105 1.25%
  51 – 65 14480 170 1.17%
Gender
  Male 12280 140 1.14% 0.203
  Female 16245 160 0.98%
Race
  White 16425 210 1.27% 0.425
  Black 3915 20 0.51%
  Hispanic 4580 30 0.65%
  Asian 830 0 0%
  Native American 170 10 5.88%
  Other 1185 20 1.69%
Median household income, in percentile
  0-25th 8215 45 0.55% <0.001
  26th-50th 7425 105 1.41%
  51st-75th 6775 60 0.89%
  76th-100th 5315 75 1.41%
Primary payer/insurance
  Medicare 4900 60 1.22% 0.884
  Medicaid 6345 65 1.02%
  Private insurance 12950 140 1.08%
  Uninsured 4255 35 0.82%
Hospital ownership
  Public 4370 55 1.26% 0.154
  Private, non-profit 20965 215 1.02%
  Private, for-profit 3190 30 0.94%
Hospital location and teaching status
  Rural, non-teaching 1320 10 0.78% <0.001
  Urban, non-teaching 8125 25 0.31%
  Urban, teaching 19080 265 1.39%
Hospital bed size
  Small 3160 40 1.27% 0.121
  Medium 7150 80 1.12%
  Large 18215 180 0.99%
Hospital region
  Northeast 5845 70 1.20% 0.079
  Midwest 6480 45 0.70%
  South 10055 95 0.94%
  West 6145 90 1.46%
Comorbid risk factors
  Diabetes 6070 85 1.40% 0.003
  HIV infection 3945 55 1.40% 0.023
  Bile duct perforation 20 0 0% 0.645
  Obstruction of stent 6715 55 0.82 0.033

In logistic regression model adjusted for demographics as shown in Table 2, ERCP inpatients with POI had higher odds of association with comorbid HIV infection (OR 1.55, 95% CI 1.13 - 2.12) and diabetes (OR 1.43, 95% CI 1.09 - 1.85). On the contrary, bile duct perforation and obstruction of the stent were not associated with higher odds for POI after controlling for other risk factors. 

Characteristic Odds Ratio 95% Confidence Interval P-value
Lower Upper
Age at admission (in years) 
  18 – 35 Reference
  36 – 50 2.65 1.69 4.12 <0.001
  51 – 65 2.26 1.45 3.50 <0.001
Gender
  Male Reference
  Female 0.94 0.75 1.19 0.636
Race
  White Reference
  Black 0.39 0.24 0.61 <0.01
  Hispanic 0.54 0.37 0.80 0.159
  Asian <0.01 <0.01   0.990
  Native American 4.74 2.44 9.19 <0.01
  Other 1.28 0.81 2.04 0.292
Comorbid risk factors
  None Reference
  Diabetes 1.43 1.09 1.85 0.008
  HIV infection 1.55 1.13 2.12 0.006
  Bile duct perforation <0.01 <0.01   0.998
  Obstruction of stent 0.61 0.45 0.83 0.002

Table 3 shows the results of the independent sample T-test. ERCP with POI inpatients had a significantly longer LOS by 5.2 days (95% CI -0.49 to -5.98) and higher total charges by USD 53,966 (95% CI -61,404 to -46,527) than inpatients without POI.

Variable Mean (Standard deviation) Mean difference
Non-POI POI Estimate 95% CI P-value
Length of stay, days 5.8 (6.66) 11.0 (8.41) -5.22 -0.49 to -5.98 <0.001
Total charges, USD 53,554 (63,909) 107,520 (124,100) -53,966 -61,404 to -46,527 <0.001

Discussion

From our study, the majority of risk factors for the post-ERCP infection were amongst white males with a median age of 42 (interquartile range 35 to 50 years). The exact source of infection has not been demonstrated, but pancreatic sepsis or abscess can be caused by the introduction of dangerous materials into a stagnant duct system, with the endoscopic cannula or contrast medium [11]. Although there is no absolute evidence for the effectiveness of routine antibiotic prophylaxis on the frequency of septic complication after ERCP, the rate of bacteremia seems to decrease significantly. After ERCP, there is often temporary abdominal discomfort, transient fever, and hyperamylasemia [12].

According to Kullman et al., the occurrence of POI is associated with therapeutic ERCP, but due to a small sample population, there were not able to reach statistically significant differences between both diagnostic and therapeutic procedures [11]. Mingmei et al. suggested that POI occurs irrespective of diagnostic and therapeutic ERCP procedure because they excluded all the infections that occurred preoperatively [13]. Its clinical features, management, and the outcome are poorly characterized in the literature [12]. In a recent study, (200 procedures in 22 months) the reported rate of POI was less than 5%, with a tendency to reduce with increased experience of the practitioner [12]. In our study, from a total of 28,525 ERCP performed, only 300 inpatients were diagnosed with comorbid POI.

POI was seen more in diabetes due to hyperglycemia, which causes increased virulence of infectious microorganisms and apoptosis of polymorphonuclear neutrophils. Diabetic patients have decreased neutrophil function, decreased T-lymphocytes response, and humoral immunity disorders [14]. According to our study, post-ERCP infection is more common in Native Americans as they live in rural areas and high prevalence of hospitalization because they have greater exposure to environmental risk factors for infection. This can be overcome if they improve access to water, sanitation, and alternative sources of heat in rural areas [15].

The most prevalent isolates were E. faecium and E. coli seen by the studies conducted by Rerknimitr et al. and Thosani et al. in patients undergoing ERCP [16-17]. Prophylactic antibiotics are the most effective prevention against infections from gram-negative bacteria and Enterococcus spp. Guidelines by the American Society for Gastrointestinal Endoscopy (ASGE) and the British Society of Gastroenterology Endoscopy advocate prevention for patients with biliary obstruction [18-19], whereas the European Society of Gastrointestinal Endoscopy [20] recommends prophylaxis for every type of therapeutic ERCP. ASGE guidelines currently recommend that antibiotic prophylaxis should be considered before an ERCP in patients with known or suspected biliary obstruction [18] in which there is a possibility that complete drainage may not be achieved, such as in patients with a hilar stricture and primary sclerosing cholangitis [11]. When biliary drainage is incomplete despite an ERCP, continuation of antibiotics after the procedure is recommended. Antibiotics that cover biliary flora, such as enteric gram-negative organisms and enterococci, should be used [18].

Preoperative admission to an intensive care unit (ICU) increased the odds of POI as compared to hospital admission outside of an ICU. Being admitted at least one day before procedure compared to the same-day procedure was associated with a significant increase in the odds of POI. There was no significant independent association between preoperative length of stay and risk of POI while POI and postoperative length of stay were significantly associated [21]. The main goal is to identify the risk factors and to prevent POI with antibiotics like intravenous moxifloxacin (400mg/day) or ceftriaxone (2g/day) administered for three days or more if the patient developed signs and symptoms of cholangitis or septicemia [22].

This study has a few limitations. Some cases of bacteremia would have gone undetected because of a lack of blood culture results during hospitalization. Also, there might be under-reporting of co-diagnoses of POI during discharge diagnoses coding inpatient records. Another issue is that our study monitored all ERCP cases during hospitalization, but post-discharge surveillance was not carried out. Post-discharge monitoring could be performed to identify POI that was not reported and documented in our study sample.

Conclusions

The risk factors for post-ERCP infection are middle-aged adults (36 to 50 years), Native American, immunodeficiency, and diabetes. The detailed epidemiological data for infections after ERCP in US hospitals may improve our understanding of the risk factors of post-ERCP infections and potential prevention and treatment measures. Our study indicates that the incidence of post-ERCP infection is high among these high-risk patients, and these enables the clinicians to consider these predictors when they start antibiotic prophylaxis. It is important to manage post-ERCP infections as they increase the need for acute inpatient care due to longer LOS and higher total charges compared to inpatients without postoperative infections.


References

  1. ASGE Standards of Practice Committee, Anderson MA, Fisher L, et al.: Complications of ERCP. Gastrointest Endosc. 2012, 75:467-473. 10.1016/j.gie.2011.07.010
  2. Szary NM, Al-Kawas FH: Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y). 2013, 9:496-504.
  3. Serrano JPR, de Moura DTH, Bernardo WM, et al.: Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Endosc Int Open. 2019, 7:E477-E486. 10.1055/a-0862-0215
  4. Iorgulescu A, Sandu I, Turcu F, Iordache N: Post-ERCP acute pancreatitis and its risk factors. J Med Life. 2013, 6:109-113.
  5. Wobser H, Gunesch A, Klebl F: Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media - a single center retrospective study. BMC Gastroenterol. 2017, 17:10. Accessed: July 25, 2019: 10.1186/s12876-017-0570-4
  6. Andriulli A, Loperfido S, Napolitano G, et al.: Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007, 102:1781-1788.
  7. Beilenhoff U, Neumann CS, Rey JF, et al.: ESGE-ESGENA Guideline: cleaning and disinfection in gastrointestinal endoscopy. Endoscopy. 2008, 40:939-957. 10.1055/s-2008-1077722
  8. Freeman ML: Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography. Curr Gastroenterol Rep. 2003, 5:145-153.
  9. Overview of the National (nationwide) Inpatient Sample (NIS). (2019). Accessed: May 15, 2019: https://www.hcup-us.ahrq.gov/nisoverview.jsp.
  10. NIS description of data elements. (2019). Accessed: May 15, 2019: https://www.hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp.
  11. Kullman E, Borch K, Lindström E, Anséhn S, Ihse I, Anderberg B: Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc. 1992, 38:444-449. 10.1016/S0016-5107(92)70474-X
  12. Peixoto A, Silva M, Macedo G: Cholangitis after endoscopic retrograde cholangiopancreatography: a rare complication?. Rev Esp Enferm Dig. 2017, 109:536-537. 10.17235/reed.2017.4771/2016
  13. Du M, Suo J, Liu B, Xing Y, Chen L, Liu Y: Post-ERCP infection and its epidemiological and clinical characteristics in a large chinese tertiary hospital: a 4-year surveillance study. Antimicrob Resist Infect Control. 2017, 6:131. 10.1186/s13756-017-0290-0
  14. Casqueiro J, Casqueiro J, Alves C: Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012, 16:S27-S36. 10.4103/2230-8210.94253
  15. Gounder PP, Holman RC, Seeman SM, et al.: Infectious disease hospitalizations among american indian/alaska native and non-american indian/alaska native persons in Alaska, 2010-2011. Public Health Rep. 2017, 132:65-75. 10.1177/0033354916679807
  16. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S: Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002, 56:885-889. 10.1067/mge.2002.129604
  17. Thosani N, Zubarik RS, Kochar R, Kothari S, Sardana N, Nguyen T, Banerjee S: Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP. Endoscopy. 2016, 48:424-431. 10.1055/s-0042-101407
  18. Hirota WK, Petersen K, Baron TH, et al.: Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2003, 58:475-482. 10.1067/S0016-5107(03)01883-2
  19. Mani V, Cartwright K, Dooley J, Swarbrick E, Fairclough P, Oakley C: Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a working party for the British Society of Gastroenterology Endoscopy Committee. Endoscopy. 1997, 29:114-119. 10.1055/s-2007-1004085
  20. Rey JR, Axon A, Budzynska A, Kruse A, Nowak A: Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy. 1998, 30:318-324.
  21. Mujagic E, Marti WR, Coslovsky M, et al.: Associations of hospital length of stay with surgical site infections. World J Surg. 2018, 42:3888-3896. 10.1007/s00268-018-4733-4
  22. Kim NH, Kim HJ, Bang KB: Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis. Hepatobiliary Pancreat Dis Int. 2017, 16:512-518. 10.1016/S1499-3872(17)60056-0
Original article
peer-reviewed

Burdens of Postoperative Infection in Endoscopic Retrograde Cholangiopancreatography Inpatients


Author Information

Shanthini Kuduva Rajan

Internal Medicine, Tirunelveli Medical College, Tirunelveli, IND

Sowmya Madireddy

Internal Medicine, Mamata Medical College, Khammam, IND

Paul Rahul Jaladi

Internal Medicine, Rajiv Gandhi Institute of Medical Sciences, Kadapa, IND

Virendrasinh Ravat

Internal Medicine, Larkin Community Hospital, South Miami, USA

Anum Masroor

Medicine, Khyber Medical College, Khyber Pakhtunkhwa, PAK

Uwandu Queeneth

Medicine, Maastricht University, Maastricht, NLD

Wahida Rashid

Internal Medicine, Dhaka Medical College, Dhaka, BGD

Rikinkumar S. Patel Corresponding Author

Psychiatry, Griffin Memorial Hospital, Norman, USA


Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Original article
peer-reviewed

Burdens of Postoperative Infection in Endoscopic Retrograde Cholangiopancreatography Inpatients


Figures etc.

SIQ
-
RATED BY 0 READERS
CONTRIBUTE RATING

Scholary Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.